2m 2m 2m 2m 2m 2m 2m
PRELUDE THERAP (PRLD)
NASDAQ
$3.46-$0.06 (-1.85%)
Price as of Nov 13, 2026 1:54 PM EST- $229.1MMarket Cap
- 133.11%1-Year Change
- BiotechnologyIndustry
PRELUDE THERAP (PRLD)
$3.46-$0.06 (-1.85%)
PRLD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.52 | ||
Change | -$0.26 (-6.88%) | ||
Open | $3.73 | ||
High | $3.73 | ||
Low | $3.50 | ||
Previous Close | $3.78 | ||
Volume | 230,883 | ||
30-Day Average Volume | 386,547 | ||
1-Week Change | -0.98% | ||
1-Month Change | -5.88% | ||
1-Year Change | 133.11% | ||
3-Year Change | 16.94% | ||
5-Year Change | -78.27% | ||
Fundamentals | |||
Shares Outstanding | 65.1M | ||
Total Assets | $189.4M | ||
Market Cap | $229.1M | ||
Enterprise Value | $202.7M | ||
Period: QTR TTM FY | |||
Revenue | $5.7M | ||
Net Income | -$13.9M | ||
Free Cash Flow | -$15.6M | ||
EBIT | -$13.9M | ||
EBITDA | -$13.6M | ||
Net Working Capital | $116.9M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 36 | ||
P/B | 2 | ||
P/E | -25 | ||
PEG | 3 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue